Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/15/2012US20120288496 Notch-Binding Agents and Antagonists and Methods of Use Thereof
11/15/2012US20120288495 Therapeutic compositions and methods
11/15/2012US20120288494 Anti-IL-12/IL-23 antibodies and uses thereof
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/15/2012US20120288492 NOVEL PYRIMIDINE COMPOUNDS AS mTOR AND PI3K INHIBITORS
11/15/2012US20120288484 Cells, compositions and methods
11/15/2012US20120288476 Structure and use of 5' phosphate oligonucleotides
11/15/2012CA2848173A1 Ceramide anionic liposome compositions
11/15/2012CA2835705A1 Thiazole compounds, methods for preparation and use thereof
11/15/2012CA2835624A1 Treatments for gastrointestinal disorders
11/15/2012CA2835603A1 Antibody capable of specifically recognizing transferrin receptor
11/15/2012CA2835576A1 Protein-active agent conjugates and method for preparing the same
11/15/2012CA2835478A1 Substituted indazole derivatives active as kinase inhibitors
11/15/2012CA2835422A1 Spiro-oxindole mdm2 antagonists
11/15/2012CA2835412A1 Fiduciary markers and methods of placement
11/15/2012CA2835325A1 Compositions and methods for the prevention of esophageal cancer
11/15/2012CA2835286A1 Carbonic anhydrase targeting agents and methods of using same
11/15/2012CA2835203A1 Compositions and methods for treating cancer
11/15/2012CA2834777A1 Herbal composition for treating cancer
11/15/2012CA2834745A1 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
11/15/2012CA2833554A1 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
11/14/2012EP2522727A1 Highly functional bispecific antibody
11/14/2012EP2522654A2 Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient
11/14/2012EP2522653A2 Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient
11/14/2012EP2522397A1 Combination therapies using HDAC inhibitors
11/14/2012EP2522396A1 Combination therapies using HDAC inhibitors
11/14/2012EP2522395A1 Combination therapies using HDAC inhibitors
11/14/2012EP2522356A2 Bioactive fraction of petiveria alliacea, pharmaceutical composition containing same, and combination with immunostimulants for treating cancer
11/14/2012EP2522352A1 Methods for cancer therapy and stem cell modulation
11/14/2012EP2522341A1 Pharmaceutical compositions comprising Neuropilin inhibitors, and their use for the prevention and/or treatment of angiogenic disorders and cancers
11/14/2012EP2522338A2 Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy
11/14/2012EP2521913A1 Methods and compositions for treating cancer
11/14/2012EP2521785A2 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
11/14/2012EP2521724A2 Agents and methods for treating ischemic and other diseases
11/14/2012EP2521707A1 Bisphenol derivatives and their use as androgen receptor activity modulators
11/14/2012EP2521555A1 Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors
11/14/2012EP2521548A2 Quinazolin-4(3a)-one derivatives and methods of use thereof
11/14/2012EP2521543A1 A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer
11/14/2012EP2521541A2 Prophylaxis of skin cancer with retinamides
11/14/2012EP2521451A1 Hedgehog inhibitors
11/14/2012EP2521447A1 Fatty acid fumarate derivatives and their uses
11/14/2012CN1675250B Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
11/14/2012CN102782155A Compositions and methods for microrna expession profiling in plasma of lung cancer
11/14/2012CN102782139A Novel therapeutic RNA interference technology targeted to the PDX-1 oncogene in PDX-1 expressing neuroendocrine tumors
11/14/2012CN102782133A SiRNA for inhibiting c-Met expression and an anti-cancer composition comprising the same
11/14/2012CN102781965A Compositions and methods for the transport of therapeutic agents
11/14/2012CN102781964A Anti-CDH3 antibodies and uses thereof
11/14/2012CN102781943A Benzodiazepine bromodomain inhibitor
11/14/2012CN102781940A Substituted imidazopyridinyl-aminopyridine compounds
11/14/2012CN102781933A Substituted benzoazepines as toll-like receptor modulators
11/14/2012CN102781931A 5-alkynyl pyrimidines and their use as kinase inhibitors
11/14/2012CN102781923A 5-alkynyl-pyrimidines
11/14/2012CN102781919A Amidoacridine derivatives useful as selective inhibitors of ubiquitin specific protease 7
11/14/2012CN102781472A Radiation therapy agent
11/14/2012CN102781454A Microvesicles (MV) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
11/14/2012CN102781447A Aqueous solution comprising 3-quinuclidinones for the treatment of hyperproliferative, autoimmune and heart disease
11/14/2012CN102781444A Antitumor agent or postoperative adjuvant chemotherapeutic agent for treatment of hepatocellular carcinoma
11/14/2012CN102781442A Method of treating scars and beta-catenin-mediated disorders using nefopam compounds
11/14/2012CN102778566A Application of DLK1 in diagnosis and prognosis of liver cancer
11/14/2012CN102776285A Composition for the diagnosis, prevention or treatment of diseases related to cells expressing IL-8 or GRO-alpha
11/14/2012CN102776264A TNF-alpha short peptide related to apoptosis or necrosis and application thereof
11/14/2012CN102776235A Recombinant expression plasmid and application thereof in preparing anti-tumor immunogene therapeutic medicament
11/14/2012CN102776195A MicroRNA (micro ribonucleic acid) for regulating gene expression of B7-H4 (a molecule of the B7 family)
11/14/2012CN102776194A MicroRNA (micro ribonucleic acid) for regulating gene expression of PTEN (phosphatase and tensin homolog)
11/14/2012CN102776192A MicroRNA (micro ribonucleic acid) for regulating gene expression of B7-H4 (a molecule of the B7 family)
11/14/2012CN102776129A Isaria cretacea and application thereof
11/14/2012CN102775596A Paclitaxel (PTX) derivative, its preparation method and its use
11/14/2012CN102775515A Amphiphilic chitosan derivatives, and preparation method and application thereof
11/14/2012CN102775502A Alpha-interferon fusion protein
11/14/2012CN102775501A Interleukin 21 (IL-21) medicine for cancer therapy
11/14/2012CN102775500A Chimeric antigen receptor iRGD-scFv (G250)-CD8-CD28-CD137-CD3zeta and application thereof
11/14/2012CN102775493A IL-1beta binding antibodies and fragments thereof
11/14/2012CN102775491A Preparation method and application of single-chain human apoptosis-2 ligand (Apo2L) trimer protein
11/14/2012CN102775490A Secretory protein with migration activity and application thereof
11/14/2012CN102775487A Artificial targeted fusion protein and protein conjugate, and preparation method and application thereof
11/14/2012CN102775474A Polypeptide and applications thereof
11/14/2012CN102775472A Aprotinin and analogue as carriers across the blood-brain barrier
11/14/2012CN102775457A Nucleoside dinaphthalene diimide derivative, and synthetic method and application thereof
11/14/2012CN102775449A 1, 7-meta dicarbadecaborane carboxylic acid triphenyl stannic chloride compound as well as preparation method and application of compound
11/14/2012CN102775429A Preparation and application of unsaturation demethylation cantharides acid silver polymer
11/14/2012CN102775428A Pyrazole alkanol-copper complex and preparation method and application thereof
11/14/2012CN102775427A Antibiotic Tetrathiazomycin A and preparation method thereof and application in preparing antineoplastic drugs
11/14/2012CN102775411A Aryl ethynyl benzamide compound used as protein kinase inhibitor
11/14/2012CN102775408A Stable amorphous 5-methyltetrahydrofolate salt and preparation method thereof
11/14/2012CN102775407A Stable 5-methyltetrahydrofolate crystal form and preparation method thereof
11/14/2012CN102775400A N-(4-(4-ethyl piperazine-1-yl)pyrimidine-2-yl)amide or pharmaceutically acceptable salt thereof, and preparation method and application thereof
11/14/2012CN102775389A Preparation method of N-substituted-4-(7-chloro-quinoline -4-amino)-benzamide derivatives, and application thereof
11/14/2012CN102775385A N-substituted phenyl-N'-substituted heterocyclic urea compounds and application of same as anti-cancer drugs
11/14/2012CN102775384A Broussone-tine I and J analogue and preparation method and applications thereof
11/14/2012CN102775381A Substituted hydrazide compound, and its preparation method, medicinal compositions and application
11/14/2012CN102775376A Chromanone compound, and preparation method and application thereof
11/14/2012CN102775368A Thiazole compound, and preparation method and application thereof
11/14/2012CN102775356A 4-aminoquinazoline derivative and application thereof
11/14/2012CN102775337A 9, 10-ring-opening steroidal compounds, preparation method and application thereof
11/14/2012CN102775336A Raphanin derivative, and preparation method and application thereof
11/14/2012CN102772809A Nano magnetic control agglomeration chemotherapeutic pharmaceutical composition and preparation method thereof
11/14/2012CN102772806A Application of micromolecular nucleic acid miR-302 for treating or preventing testicular cancer
11/14/2012CN102772805A Application of product capable of restraining MPG expression for enabling cell to stay at first gap (G1)
11/14/2012CN102772804A Application of MAOA (monoamine oxidase) gene in liver cancer treatment
11/14/2012CN102772803A Applications of UNC5CL and its coding protein
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 2211